Monneret, Guillaume http://orcid.org/0000-0002-9961-5739
Voirin, Nicolas
Richard, Jean-Christophe
Cour, Martin
Rimmelé, Thomas
Garnier, Lorna
Yonis, Hodane
Coudereau, Remy
Gossez, Morgane
Malcus, Christophe
Wallet, Florent
Delignette, Marie-Charlotte
Dailler, Frederic
Buisson, Marielle
Argaud, Laurent
Lukaszewicz, Anne-Claire
Venet, Fabienne
,
Pescarmona, Remi
Lombard, Christine
Perret, Magali
Villard, Marine
Groussaud, Marie
Itah, Laetitia
Boussaha, Inesse
Poitevin-Later, Françoise
Simon, Marie
Dargent, Auguste
Bertrand, Pierre-Jean
Stevic, Neven
Provent, Marion
Bignet, Laurie
Cerro, Valérie
Bitker, Laurent
Mezidi, Mehdi
Baboi, Loredana
Funding for this research was provided by:
Fondation Hospices Civils de Lyon (--)
Fondation HCL (--)
Université Claude Bernard Lyon 1 (--)
Région Auvergne-Rhône-Alpes (--)
Article History
Received: 18 December 2023
Accepted: 12 May 2024
First Online: 18 May 2024
Declarations
:
: This project was part of an ongoing prospective observational clinical study (RICO, REA-IMMUNO-COVID). It was approved by ethics committee (Comité de Protection des Personnes Ile de France 1—N°IRB / IORG #: IORG0009918) under agreement number 2020-A01079-30. This clinical study was registered at ClinicalTrials.gov (NCT04392401). Oral information and non-opposition to inclusion in the study were mandatory and were systematically obtained before any blood sample was drawn. This was recorded in patients’ clinical files. If a patient was unable to consent directly, non-opposition was obtained from the patient’s legally authorized representative and reconfirmed from the patient at the earliest opportunity.
: The authors declare no competing financial interests in relation to the work.
: Not applicable.